Is it Possible to Treat Osteosarcoma Using Oligonucleotides Confined into Controlled Release Drug Delivery Systems?

---

Atıf İçin Kopyala

TOPUK S., Akyuva Y., Karaaslan N., Mutlu C. A., Yilmaz I., Isyar M., ...Daha Fazla

CURRENT PHARMACEUTICAL BIOTECHNOLOGY, cilt.18, sa.6, ss.516-522, 2017 (SCI-Expanded)

• Yayın Türü: Makale / Tam Makale
• Cilt numarası: 18 Sayı: 6
• Basım Tarihi: 2017
• Doi Numarası: 10.2174/1389201018666170615083455
• Dergi Adı: CURRENT PHARMACEUTICAL BIOTECHNOLOGY
• Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
• Sayfa Sayıları: ss.516-522
• Sivas Cumhuriyet Üniversitesi Adresli: Evet

Özet

Purpose: The present study aimed to analyze the researches that are at the experimental phase concerning osteosarcoma treatment. The researches included drug delivery systems which allow controlled release and imbue small interfering-/micro-ribonucleic acid.